Details
Original language | English |
---|---|
Pages (from-to) | 247-254 |
Number of pages | 8 |
Journal | European Journal of Clinical Nutrition |
Volume | 65 |
Issue number | 2 |
Publication status | Published - Feb 2011 |
Abstract
Background: There is a debate currently about whether different chemical forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are absorbed in an identical way. The objective of this study was to investigate the response of the omega-3 index, the percentage of EPA + DHA in red blood cell membranes, to supplementation with two different omega-3 fatty acid (n-3 FA) formulations in humans.Design: The study was conducted as a double-blinded placebo-controlled trial. A total of 150 volunteers was randomly assigned to one of the three groups: (1) fish oil concentrate with EPA + DHA (1.01 g + 0.67 g) given as reesterified triacylglycerides (rTAG group); (2) corn oil (placebo group) or (3) fish oil concentrate with EPA + DHA (1.01 g + 0.67 g) given as ethyl ester (EE group). Volunteers consumed four gelatine-coated soft capsules daily over a period of six months. The omega-3 index was determined at baseline (t0) after three months (t3) and at the end of the intervention period (t6).Results: The omega-3 index increased significantly in both groups treated with n-3 FAs from baseline to t 3 and t 6 (P<0.001). The omega-3 index increased to a greater extent in the rTAG group than in the EE group (t 3: 186 versus 161% (P<0.001); t 6: 197 versus 171% (P<0.01)).Conclusion: A six-month supplementation of identical doses of EPA + DHA led to a faster and higher increase in the omega-3 index when consumed as triacylglycerides than when consumed as ethyl esters.
Keywords
- docosahexaenoic acid, eicosapentaenoic acid, ethyl esters, N-3 fatty acids, omega-3 index, triacylglycerides
ASJC Scopus subject areas
- Medicine(all)
- Medicine (miscellaneous)
- Nursing(all)
- Nutrition and Dietetics
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: European Journal of Clinical Nutrition, Vol. 65, No. 2, 02.2011, p. 247-254.
Research output: Contribution to journal › Article › Research › peer review
}
TY - JOUR
T1 - Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters
AU - Neubronner, J.
AU - Schuchardt, Jan Philipp
AU - Kressel, G.
AU - Merkel, M.
AU - Von Schacky, C.
AU - Hahn, A.
N1 - Funding information: C von Schacky received a speaker’s honoraria from Solvay, and grant support from Sanofi-Aventis and Smartfish. He founded Omegametrix, a company offering FA analyses. A Hahn and JP Schuchardt worked as consultants for companies, which also produce and merchandise FA supplements. The authors are solely responsible for the design and conduct of the study; collection, management, analysis and interpretation of the data; as well as preparation of the manuscript.
PY - 2011/2
Y1 - 2011/2
N2 - Background: There is a debate currently about whether different chemical forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are absorbed in an identical way. The objective of this study was to investigate the response of the omega-3 index, the percentage of EPA + DHA in red blood cell membranes, to supplementation with two different omega-3 fatty acid (n-3 FA) formulations in humans.Design: The study was conducted as a double-blinded placebo-controlled trial. A total of 150 volunteers was randomly assigned to one of the three groups: (1) fish oil concentrate with EPA + DHA (1.01 g + 0.67 g) given as reesterified triacylglycerides (rTAG group); (2) corn oil (placebo group) or (3) fish oil concentrate with EPA + DHA (1.01 g + 0.67 g) given as ethyl ester (EE group). Volunteers consumed four gelatine-coated soft capsules daily over a period of six months. The omega-3 index was determined at baseline (t0) after three months (t3) and at the end of the intervention period (t6).Results: The omega-3 index increased significantly in both groups treated with n-3 FAs from baseline to t 3 and t 6 (P<0.001). The omega-3 index increased to a greater extent in the rTAG group than in the EE group (t 3: 186 versus 161% (P<0.001); t 6: 197 versus 171% (P<0.01)).Conclusion: A six-month supplementation of identical doses of EPA + DHA led to a faster and higher increase in the omega-3 index when consumed as triacylglycerides than when consumed as ethyl esters.
AB - Background: There is a debate currently about whether different chemical forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are absorbed in an identical way. The objective of this study was to investigate the response of the omega-3 index, the percentage of EPA + DHA in red blood cell membranes, to supplementation with two different omega-3 fatty acid (n-3 FA) formulations in humans.Design: The study was conducted as a double-blinded placebo-controlled trial. A total of 150 volunteers was randomly assigned to one of the three groups: (1) fish oil concentrate with EPA + DHA (1.01 g + 0.67 g) given as reesterified triacylglycerides (rTAG group); (2) corn oil (placebo group) or (3) fish oil concentrate with EPA + DHA (1.01 g + 0.67 g) given as ethyl ester (EE group). Volunteers consumed four gelatine-coated soft capsules daily over a period of six months. The omega-3 index was determined at baseline (t0) after three months (t3) and at the end of the intervention period (t6).Results: The omega-3 index increased significantly in both groups treated with n-3 FAs from baseline to t 3 and t 6 (P<0.001). The omega-3 index increased to a greater extent in the rTAG group than in the EE group (t 3: 186 versus 161% (P<0.001); t 6: 197 versus 171% (P<0.01)).Conclusion: A six-month supplementation of identical doses of EPA + DHA led to a faster and higher increase in the omega-3 index when consumed as triacylglycerides than when consumed as ethyl esters.
KW - docosahexaenoic acid
KW - eicosapentaenoic acid
KW - ethyl esters
KW - N-3 fatty acids
KW - omega-3 index
KW - triacylglycerides
UR - http://www.scopus.com/inward/record.url?scp=79651470482&partnerID=8YFLogxK
U2 - 10.1038/ejcn.2010.239
DO - 10.1038/ejcn.2010.239
M3 - Article
C2 - 21063431
AN - SCOPUS:79651470482
VL - 65
SP - 247
EP - 254
JO - European Journal of Clinical Nutrition
JF - European Journal of Clinical Nutrition
SN - 0954-3007
IS - 2
ER -